Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

JC Stoof

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Parkinson Disease

Procedures

Tomography, Emission-Computed, Single-Photon

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
39
Drukarch, Benjamin
20
Wolters, Erik
15
Booij, Jan
13
Langeveld, CH
11
van Royen, EA
10
Winogrodzka, Ania
10
Bergmans, PL
9
Jongenelen, C A M
9
Tissingh, G
8
Savelkoul, Paul
7
Vandenbroucke-Grauls, Christina
6
Van Muiswinkel, Freek
6
Andringa, Gerda
6
Cools, Alexander
6
Heimans, Jan

Sign-in to see all Coauthors

Publications

TOP 3
Winogrodzka A; Bergmans P; Booij J; van Royen E A; Stoof J C; Wolters E C
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
Winogrodzka A; Wagenaar R C; Bergmans P; Vellinga A; Booij J; van Royen E A; van Emmerik R E; Stoof J C; Wolters E C
Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients.
Berendse H W; Booij J; Francot C M; Bergmans P L; Hijman R; Stoof J C; Wolters E C
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of JC Stoof (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2003: Winogrodzka A; Bergmans P; Booij J; van Royen E A; Stoof J C; Wolters E C
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2003;74(3):294-8.
2001: Winogrodzka A; Wagenaar R C; Bergmans P; Vellinga A; Booij J; van Royen E A; van Emmerik R E; Stoof J C; Wolters E C
Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients.
Movement disorders : official journal of the Movement Disorder Society 2001;16(6):1033-40.
2001: Berendse H W; Booij J; Francot C M; Bergmans P L; Hijman R; Stoof J C; Wolters E C
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell.
Annals of neurology 2001;50(1):34-41.
2001: Spaargaren J; Stoof J; Fennema H; Coutinho R; Savelkoul P
Amplified fragment length polymorphism fingerprinting for identification of a core group of Neisseria gonorrhoeae transmitters in the population attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands.
Journal of clinical microbiology 2001;39(6):2335-7.
2001: Koeleman J G; van der Bijl M W; Stoof J; Vandenbroucke-Grauls C M; Savelkoul P H
Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2001;22(5):284-8.
2001: Tissingh G; Berendse H W; Bergmans P; DeWaard R; Drukarch B; Stoof J C; Wolters E C
Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis.
Movement disorders : official journal of the Movement Disorder Society 2001;16(1):41-6.
2001: Koeleman J G; Stoof J; Van Der Bijl M W; Vandenbroucke-Grauls C M; Savelkoul P H
Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR.
Journal of clinical microbiology 2001;39(1):8-13.
2000: Van Der Zwet W C; Parlevliet G A; Savelkoul P H; Stoof J; Kaiser A M; Van Furth A M; Vandenbroucke-Grauls C M
Outbreak of Bacillus cereus infections in a neonatal intensive care unit traced to balloons used in manual ventilation.
Journal of clinical microbiology 2000;38(11):4131-6.
2000: Morré S A; Ossewaarde J M; Savelkoul P H; Stoof J; Meijer C J; van den Brule A J
Analysis of genetic heterogeneity in Chlamydia trachomatis clinical isolates of serovars D, E, and F by amplified fragment length polymorphism.
Journal of clinical microbiology 2000;38(9):3463-6.
2000: Andringa G; van Oosten R V; Unger W; Hafmans T G; Veening J; Stoof J C; Cools A R
Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.
The European journal of neuroscience 2000;12(8):3033-43.
2000: Wolters E C; Francot C; Bergmans P; Winogrodzka A; Booij J; Berendse H W; Stoof J C
Preclinical (premotor) Parkinson's disease.
Journal of neurology 2000;247 Suppl 2():II103-9.
2000: Simoons-Smit A M; Savelkoul P H; Stoof J; Starink T M; Vandenbroucke-Grauls C M
Transmission of Staphylococcus aureus between humans and domestic animals in a household.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(2):150-2.
1999: Andringa G; Stoof J C; Cools A R
Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia.
Psychopharmacology 1999;146(3):328-34.
1999: van der Zwet W C; Parlevliet G A; Savelkoul P H; Stoof J; Kaiser A M; Koeleman J G; Vandenbroucke-Grauls C M
Nosocomial outbreak of gentamicin-resistant Klebsiella pneumoniae in a neonatal intensive care unit controlled by a change in antibiotic policy.
The Journal of hospital infection 1999;42(4):295-302.
1999: Stoof J C; Winogrodzka A; van Muiswinkel F L; Wolters E C; Voorn P; Groenewegen H J; Booij J; Drukarch B
Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy.
European journal of pharmacology 1999;375(1-3):75-86.
1999: van Doorn N E; Namavar F; Sparrius M; Stoof J; van Rees E P; van Doorn L J; Vandenbroucke-Grauls C M
Helicobacter pylori-associated gastritis in mice is host and strain specific.
Infection and immunity 1999;67(6):3040-6.
1999: Andringa G; Lubbers L; Drukarch B; Stoof J C; Cools A R
The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958.
Behavioural pharmacology 1999;10(2):175-82.
1999: Andringa G; Vermeulen R J; Drukarch B; Renier W O; Stoof J C; Cools A R
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297.
Behavioural pharmacology 1999;10(2):163-73.
1999: Andringa G; Drukarch B; Leysen J E; Cools A R; Stoof J C
The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
European journal of pharmacology 1999;364(1):33-41.
1998: Booij J; Habraken J B; Bergmans P; Tissingh G; Winogrodzka A; Wolters E C; Janssen A G; Stoof J C; van Royen E A
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(11):1879-84.
1998: van de Witte S V; Drukarch B; Stoof J C; Voorn P
Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist.
Brain research. Molecular brain research 1998;61(1-2):219-23.
1998: Koeleman J G; Stoof J; Biesmans D J; Savelkoul P H; Vandenbroucke-Grauls C M
Comparison of amplified ribosomal DNA restriction analysis, random amplified polymorphic DNA analysis, and amplified fragment length polymorphism fingerprinting for identification of Acinetobacter genomic species and typing of Acinetobacter baumannii.
Journal of clinical microbiology 1998;36(9):2522-9.
1998: Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen A G; van Royen E A; Stoof J C; Wolters E C
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(7):1143-8.
1998: Drukarch B; Schepens E; Stoof J C; Langeveld C H; Van Muiswinkel F L
Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species.
Free radical biology & medicine 1998;25(2):217-20.
1998: Tissingh G; Bergmans P; Booij J; Winogrodzka A; van Royen E A; Stoof J C; Wolters E C
Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.
Journal of neurology 1998;245(1):14-20.
1998: Andringa G; Vermeulen R J; Drukarch B; Stoof J C; Cools A R
Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease.
Advances in pharmacology (San Diego, Calif.) 1998;42():792-5.
1997: Custers F G; Leysen J E; Stoof J C; Herscheid J D
Vesamicol and some of its derivatives: questionable ligands for selectively labelling acetylcholine transporters in rat brain.
European journal of pharmacology 1997;338(2):177-83.
1997: Drukarch B; Schepens E; Jongenelen C A; Stoof J C; Langeveld C H
Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency.
Brain research 1997;770(1-2):123-30.
1997: Tissingh G; Bergmans P; Booij J; Winogrodzka A; Stoof J C; Wolters E C; Van Royen E A
[123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls.
European journal of nuclear medicine 1997;24(9):1171-4.
1997: Tissingh G; Bergmans P; Winogrodzka A; Stoof J C; Wolters E C; Booij J; Van Royen E A
Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1271-2.
1997: Pinna A; Morelli M; Drukarch B; Stoof J C
Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue.
European journal of pharmacology 1997;331(1):23-6.
1997: Drukarch B; Schepens E; Stoof J C; Langeveld C H
Anethole dithiolethione prevents oxidative damage in glutathione-depleted astrocytes.
European journal of pharmacology 1997;329(2-3):259-62.
1997: Booij J; Tissingh G; Boer G J; Speelman J D; Stoof J C; Janssen A G; Wolters E C; van Royen E A
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1997;62(2):133-40.
1997: Booij J; Tissingh G; Winogrodzka A; Boer G J; Stoof J C; Wolters E C; van Royen E A
Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.
European journal of nuclear medicine 1997;24(1):68-71.
1997: Langeveld C H; Jongenelen C A; Theeuwes J W; Baak J P; Heimans J J; Stoof J C; Peters G J
The antiproliferative effect of 8-chloro-adenosine, an active metabolite of 8-chloro-cyclic adenosine monophosphate, and disturbances in nucleic acid synthesis and cell cycle kinetics.
Biochemical pharmacology 1997;53(2):141-8.
1996: Drukarch B; Jongenelen C A; Schepens E; Langeveld C H; Stoof J C
Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(19):6038-45.
1996: Mansvelder H D; Stoof J C; Kits K S
Dihydropyridine block of omega-agatoxin IVA- and omega-conotoxin GVIA-sensitive Ca2+ channels in rat pituitary melanotropic cells.
European journal of pharmacology 1996;311(2-3):293-304.
1996: Langeveld C H; Schepens E; Jongenelen C A; Stoof J C; Hjelle O P; Ottersen O P; Drukarch B
Presence of glutathione immunoreactivity in cultured neurones and astrocytes.
Neuroreport 1996;7(11):1833-6.
1995: Vermeulen R J; Wolters E C; Tissingh G; Booij J; Janssen A G; Habraken J; Sokole-Busemann E; Stoof J C; Van Royen E A
Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease.
Nuclear medicine and biology 1995;22(8):985-91.
1995: Langeveld C H; Schepens E; Stoof J C; Bast A; Drukarch B
Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices.
Free radical biology & medicine 1995;19(2):209-17.
1995: Langeveld C H; Jongenelen C A; Schepens E; Stoof J C; Bast A; Drukarch B
Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development.
Neuroscience letters 1995;192(1):13-6.
1995: Vermeulen R J; Drukarch B; Sahadat M C; Goosen C; Schoffelmeer A N; Wolters E C; Stoof J C
Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys.
Psychopharmacology 1995;118(4):451-9.
1995: Van Muiswinkel F L; Jongenelen C A; Schepens H T; Stoof J C; Drukarch B
Effects of chronic activation of dopamine D-2 receptors in cultures of rat fetal dopaminergic neurons: indications for alterations in functional activity.
Brain research. Developmental brain research 1995;85(1):128-36.
1995: Van Muiswinkel F L; Bol J G; Ruijter J M; Stoof J C; Drukarch B; Steinbusch H W
Repeated administration of a selective dopamine D2 receptor agonist to 6-OHDA-lesioned rats does not affect the survival and outgrowth of intrastriatal fetal mesencephalic grafts.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1995;107(1):52-8.
1994: Vermeulen R J; Drukarch B; Sahadat M C; Goosen C; Wolters E C; Stoof J C
The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys.
Movement disorders : official journal of the Movement Disorder Society 1994;9(6):664-72.
1994: Vermeulen R J; Jongenelen C A; Langeveld C H; Wolters E C; Stoof J C; Drukarch B
Dopamine D1 receptor agonists display a different intrinsic activity in rat, monkey and human astrocytes.
European journal of pharmacology 1994;269(1):121-5.
1994: Schoffelmeer A N; Hogenboom F; Mulder A H; Ronken E; Stoof J C; Drukarch B
Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
Synapse (New York, N.Y.) 1994;17(3):190-5.
1994: Radhakishun F S; Westerink B H; Stoof J C; Wolterink G; van Ree J M
Subchronic treatment with the neuroleptic-like peptide desenkephalin-gamma-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of rats.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1994;4(2):127-36.
1994: Vermeulen R J; Drukarch B; Verhoeff N P; Goosen C; Sahadat M C; Wolters E C; van Royen E A; Stoof J C
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.
Synapse (New York, N.Y.) 1994;17(2):115-24.
1994: Van Muiswinkel F L; Drukarch B; Steinbusch H W; Stoof J C
Dopamine D-2 autoreceptors regulating the release of dopamine from cultured rat fetal dopaminergic neurons do not desensitize upon sustained activation: implications for the combined pharmaco- and grafting therapy in parkinsonian patients.
Experimental neurology 1994;125(2):218-27.
1993: Henselmans J M; Heyna M H; Stoof J C
Regional differences in the dopaminergic regulation of cyclic AMP formation within the rat nucleus accumbens: comparison with the striatal complex of the lizard Gekko gecko.
Neuroscience letters 1993;158(1):79-82.
1993: Vermeulen R J; Drukarch B; Sahadat M C; Goosen C; Wolters E C; Stoof J C
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys.
European journal of pharmacology 1993;235(1):143-7.
1993: Van Muiswinkel F L; Drukarch B; Steinbusch H W; Stoof J C
Chronic dopamine D2 receptor activation does not affect survival and differentiation of cultured dopaminergic neurons: morphological and neurochemical observations.
Journal of neurochemistry 1993;60(1):83-92.
1992: Langeveld C H; Jongenelen C A; Heimans J J; Stoof J C
8-Chloro-cyclic adenosine monophosphate, a novel cyclic AMP analog that inhibits human glioma cell growth in concentrations that do not induce differentiation.
Experimental neurology 1992;117(2):196-203.
1992: Langeveld C H; Jongenelen C A; Heimans J J; Stoof J C
Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro cyclic adenosine 3':5'-monophosphate.
Cancer research 1992;52(14):3994-9.
1992: Keja J A; Stoof J C; Kits K S
Dopamine D2 receptor stimulation differentially affects voltage-activated calcium channels in rat pituitary melanotropic cells.
The Journal of physiology 1992;450():409-35.
1992: Langeveld C H; van Waas M P; Stoof J C; Sutanto W; de Kloet E R; Wolbers J G; Heimans J J
Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone.
Journal of neuroscience research 1992;31(3):524-31.
1992: Stoof J C; Booij J; Drukarch B; Wolters E C
The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way.
European journal of pharmacology 1992;213(3):439-43.
1992: Drukarch B; Stoof J C
Application of functional in vitro model systems or the comparisons of the pharmacological characteristics of dopamine autoreceptors and postsynaptic D-2 receptors.
Neurochemistry international 1992;20 Suppl():69S-73S.
1992: Stoof J C; Drukarch B; de Boer P; Westerink B H
In vitro and in vivo acetylcholine release from rat striatum as a functional paradigm of signal transduction via a D-2 dopamine receptor.
Neurochemistry international 1992;20 Suppl():201S-205S.
1992: Langeveld C H; Wolbers J G; Heimans J J; Stoof J C; de Kloet E R
Hormone receptors and glioma cell growth.
Journal of neurosurgery 1992;76(1):168.
1992: Stoof J C; Drukarch B; de Boer P; Westerink B H; Groenewegen H J
Regulation of the activity of striatal cholinergic neurons by dopamine.
Neuroscience 1992;47(4):755-70.
1992: Stoof J C; Booij J; Drukarch B
Amantadine as N-methyl-D-aspartic acid receptor antagonist: new possibilities for therapeutic applications?
Clinical neurology and neurosurgery 1992;94 Suppl():S4-6.
1991: Henselmans J M; Hoogland P V; Stoof J C
Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats.
Brain research 1991;566(1-2):8-12.
1991: Henselmans J M; Stoof J C
Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation in rat nucleus accumbens and neostriatum.
Brain research 1991;566(1-2):1-7.
1991: Drukarch B; Schepens E; Stoof J C
Sustained activation does not desensitize the dopamine D2 receptor-mediated control of evoked in vitro release of radiolabeled acetylcholine from rat striatum.
European journal of pharmacology 1991;196(2):209-12.
1991: Keja J A; Stoof J C; Kits K S
Voltage-activated currents through calcium channels in rat pituitary melanotrophic cells.
Neuroendocrinology 1991;53(4):349-59.
1991: Werkman T R; van Minnen J; Voorn P; Steinbusch H W; Westerink B H; De Vlieger T A; Stoof J C
Localization of dopamine and its relation to the growth hormone producing cells in the central nervous system of the snail Lymnaea stagnalis.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1991;85(1):1-9.
1990: Drukarch B; Schepens E; Dolleman-Van der Weel M J; De Boer P; Van Vliet B J; Stoof J C
Lack of a dopamine autoreceptor selective profile of B-HT 920 in functional in vitro model systems of D2 receptors in rat striatum.
European journal of pharmacology 1990;187(2):257-69.
1990: Werkman T R; De Vlieger T A; Stoof J C
Indications for a hormonal function of dopamine in the central nervous system of the snail Lymnaea stagnalis.
Neuroscience letters 1990;108(1-2):167-72.
1990: Bruyn R P; Stoof J C
The quinolinic acid hypothesis in Huntington's chorea.
Journal of the neurological sciences 1990;95(1):29-38.
1990: Drukarch B; Schepens E; Stoof J C
Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.
Neuroscience 1990;37(1):1-9.
1990: Drukarch B; Stoof J C
D-2 dopamine autoreceptor selective drugs: do they really exist?
Life sciences 1990;47(5):361-76.
1989: Drukarch B; Kits K S; Leysen J E; Schepens E; Stoof J C
Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channels.
British journal of pharmacology 1989;98(1):113-8.
1989: Drukarch B; Schepens E; Heimans J J; Stoof J C
Alpha 2-adrenoceptor-mediated modulation of noradrenaline release is decreased in vas deferens but not in cerebral cortex of diabetic rats.
Journal of the neurological sciences 1989;91(3):293-9.
1989: Drukarch B; Schepens E; Schoffelmeer A N; Stoof J C
Stimulation of D-2 dopamine receptors decreases the evoked in vitro release of [3H]acetylcholine from rat neostriatum: role of K+ and Ca2+.
Journal of neurochemistry 1989;52(6):1680-5.
1988: Drukarch B; Leysen J E; Stoof J C
Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease.
Life sciences 1988;42(9):1011-7.
1988: Stoof J C
Localization and pharmacology of some dopamine receptor complexes in the striatum and the pituitary gland: synaptic and son-synaptic communication.
Acta morphologica Neerlando-Scandinavica 1988;26(2-3):115-30.
1987: Radhakishun F S; Stoof J C; Mulder A H; Versteeg D H; van Ree J M
The neuroleptic-like peptide desenkephalin-gamma-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitro.
Brain research 1987;426(2):235-42.
1987: Stoof J C; Verheijden P F; Leysen J E
Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
Brain research 1987;423(1-2):364-8.
1987: Drukarch B; Kits K S; Van der Meer E G; Lodder J C; Stoof J C
9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current.
European journal of pharmacology 1987;141(1):153-7.
1987: Werkman T R; Lodder J C; De Vlieger T A; Stoof J C
Further pharmacological characterization of a D-2-like dopamine receptor on growth hormone producing cells in Lymnaea stagnalis.
European journal of pharmacology 1987;139(2):155-61.
1987: Schoffelmeer A N; Verheijden P F; Hogenboom F; Mulder A H; Stoof J C
Opioid and D-2 receptor mediated inhibition of forskolin-stimulated cyclic AMP efflux from rat neostriatal slices.
Neuropharmacology 1987;26(7A):785-7.
1987: Plantjé J F; Schipper J; Verheijden P F; Stoof J C
D2-dopamine receptors regulate the release of [3H]dopamine in rat basal hypothalamus and neurointermediate lobe of the pituitary gland.
Brain research 1987;413(2):205-12.
1987: Stoof J C; Russchen F T; Verheijden P F; Hoogland P V
A comparative study of the dopamine-acetylcholine interaction in telencephalic structures of the rat and of a reptile, the lizard Gekko gecko.
Brain research 1987;404(1-2):273-81.
1987: Plantjé J F; Steinbusch H W; Schipper J; Dijcks F A; Verheijden P F; Stoof J C
D-2 dopamine-receptors regulate the release of [3H]dopamine in rat cortical regions showing dopamine immunoreactive fibers.
Neuroscience 1987;20(1):157-68.
1986: Stoof J C; Verheijden P F
D-2 receptor stimulation inhibits cyclic AMP formation brought about by D-1 receptor stimulation in rat neostriatum but not nucleus accumbens.
European journal of pharmacology 1986;129(1-2):205-6.
1986: Schoffelmeer A N; Hansen H A; Stoof J C; Mulder A H
Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1986;6(8):2235-9.
1986: de Vlieger T A; Lodder J C; Stoof J C; Werkman T R
Dopamine receptor stimulation induces a potassium dependent hyperpolarizing response in growth hormone producing neuroendocrine cells of the gastropod mollusc Lymnaea stagnalis.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1986;83(2):429-33.
1985: Schoffelmeer A N; Hansen H A; Stoof J C; Mulder A H
Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors.
European journal of pharmacology 1985;118(3):363-6.
1985: Plantjé J F; Dijcks F A; Verheijden P F; Stoof J C
Stimulation of D-2 dopamine receptors in rat mesocortical areas inhibits the release of [3H]dopamine.
European journal of pharmacology 1985;114(3):401-2.
1984: Stoof J C; De Vlieger T A; Lodder J C
Opposing roles for D-1 and D-2 dopamine receptors in regulating the excitability of growth hormone-producing cells in the snail Lymnaea stagnalis.
European journal of pharmacology 1984;106(2):431-5.
1984: Plantjé J F; Hansen H A; Daus F J; Stoof J C
The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.
European journal of pharmacology 1984;105(1-2):73-83.
1984: Plantjé J F; Daus F J; Hansen H A; Stoof J C
SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
Naunyn-Schmiedeberg's archives of pharmacology 1984;327(2):180-2.
1983: Plantjé J F; Mulder A H; Stoof J C
3-PPP antagonizes the in vitro effects of D-1 and D-2 dopamine receptor agonists in rat neostriatum.
European journal of pharmacology 1983;91(2-3):317-20.

Sign-in to see more